Sign in

CIK 0001534120

  • Non-accelerated filer
  • Smaller reporting company

Avalo Therapeutics, Inc.

Sign in to watch
Ticker
AVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450705648
Phone
+1 410-522-8707
Business address
1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
Former names
Cerecor Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market buy Director bought 226,000 shares at an average $0.67 ($151,946)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market buy Director bought 510,000 shares at an average $0.67 ($344,133)
  7. 4 Open-market buy Director bought 140,000 shares at an average $0.80 ($111,806)
  8. 4 Open-market buy Director bought 288,000 shares at an average $0.80 ($231,564)
  9. 4 Open-market buy Director bought 312,000 shares at an average $0.88 ($274,486)
  10. 4 Open-market buy Director bought 455,000 shares at an average $1.00 ($452,768)
  11. 4 Open-market buy Director bought 645,000 shares at an average $1.00 ($642,931)
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market buy Chief Medical Officer bought 6,371 shares at $1.57 ($10,002)
  19. 4 Open-market buy Chief Accounting Officer bought 955 shares at $1.57 ($1,499)
  20. 4 Open-market buy Chief Commercial Officer bought 1,093 shares at $1.57 ($1,716)

Page 9 of 28 · 552 filings